ISIS Pharmaceuticals Inc. (IONS)

Last Three Months

26-Aug-24 -- 25-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Other

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

31

0

0

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Sep-24 9:43 PM View:	30-Aug-24 Acquisition (other) $9.51K	O'Neil Patrick R. EVP CLO & General Counsel		ISIS Pharmaceuticals Inc. - IONS	1% 48.63K to 48.87K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:40 PM View:	30-Aug-24 Acquisition (other) $0.46K	Birchler Brian EVP, Corp and Development Ops		ISIS Pharmaceuticals Inc. - IONS	0% 46.16K to 46.17K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 5:30 PM View:	12-Nov-24 Private Sale (Planned) ($511.43K)	Loscalzo Joseph Director		ISIS Pharmaceuticals Inc. - IONS	(30%) 45.76K to 32.25K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:41 PM View:	30-Aug-24 Acquisition (other) $0.43K	Geary Richard S EVP, Chief Development Officer		ISIS Pharmaceuticals Inc. - IONS	(1%) 85.47K to 84.83K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 9:40 PM View:	30-Aug-24 Acquisition (other) $6.84K	Bennett C Frank EVP, Chief Scientific Officer		ISIS Pharmaceuticals Inc. - IONS	0% 79.43K to 79.61K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 5:30 PM View:	12-Nov-24 Private Sale (Planned) ($252.29K)	Monia Brett P Chief Executive Officer Director		ISIS Pharmaceuticals Inc. - IONS	(4%) 174.02K to 167.39K	0	0	--	--	Show Txns Hide Txns

14-Nov-24 5:30 PM View:	12-Nov-24 Private Sale (Planned) ($45.28K)	Swayze Eric EVP Research		ISIS Pharmaceuticals Inc. - IONS	(3%) 35.06K to 33.87K	0	0	--	--	Show Txns Hide Txns